Contact
searchSearch
HMP Global

News

News
Menthol Pain Relief Patches Recalled
12/06/2024
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling...
12/06/2024
Pharmacy Learning Network
News
OTC Lice Treatment Recalled
12/06/2024
Neogen Corporation is recalling several lots of LiceOut nonfoaming shampoo because of violations of Current Good Manufacturing Practice (CGMP) regulations.
Neogen Corporation is recalling several lots of LiceOut nonfoaming shampoo because of violations of Current Good Manufacturing Practice (CGMP) regulations.
Neogen Corporation is recalling...
12/06/2024
Pharmacy Learning Network
News
Millions of OTC Pain Relief Patches Recalled
12/06/2024
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good...
12/06/2024
Pharmacy Learning Network
News
Millions of OTC Pain Relief Patches Recalled
12/06/2024
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good...
12/06/2024
Pharmacy Learning Network
News
Respiratory Syncytial Virus Subgroups A and B Contribute Equally to the Global RSV Burden, Study Finds
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
Intravitreal Injection Recalled
12/04/2024
Medivant Healthcare is recalling syringes containing repackaged bevacizumab (Avastin) injection because of a lack of sterility assurance.
Medivant Healthcare is recalling syringes containing repackaged bevacizumab (Avastin) injection because of a lack of sterility assurance.
Medivant Healthcare is recalling...
12/04/2024
Pharmacy Learning Network
News
Capsules Pulled for CGMP Deviation
12/04/2024
Lupin Pharmaceuticals Inc. is recalling more than a half million bottles of ramipril capsules due to a deviation from Current Good Manufacturing Practice (CGMP) regulations.
Lupin Pharmaceuticals Inc. is recalling more than a half million bottles of ramipril capsules due to a deviation from Current Good Manufacturing Practice (CGMP) regulations.
Lupin Pharmaceuticals Inc. is...
12/04/2024
Pharmacy Learning Network
News
Metal Fragment in Tablet Prompts Recall
12/04/2024
A pharmacist’s report of a metal fragment embedded in a tablet has prompted a recall for bottles of lisinopril.
A pharmacist’s report of a metal fragment embedded in a tablet has prompted a recall for bottles of lisinopril.
A pharmacist’s report of a metal...
12/04/2024
Pharmacy Learning Network
News
Community Pharmacies Play a Pivotal Role in Boosting RSV Vaccine Uptake in Older Adults
11/22/2024
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
Hypertension Tablets Recalled
11/20/2024
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing...
11/20/2024
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use